Biotech executive, combative conservative Hemmati may head CBER

The search for a new leader of FDA’s Center for Biologics Evaluation and Research is accelerating as Vinay Prasad’s tenure draws to a close at the end of the month. Houman David Hemmati tops FDA Commissioner Marty Makary’s short list of candidates, according to individuals briefed on the search.

Several other individuals have been interviewed for the role. The final decision will rest with Chris Klomp, the HHS chief counselor overseeing department operations...